We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-3.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$982M
AUM Growth
+$92.9M
Cap. Flow
+$134M
Cap. Flow %
13.65%
Top 10 Hldgs %
4.69%
Holding
1,940
New
653
Increased
414
Reduced
285
Closed
576

Top Buys

Rank Stock Value
1
OPLN
Openlane
OPLN
+$4.73M
2
BBIO icon
BridgeBio Pharma
BBIO
+$4.54M
3
SPH icon
Suburban Propane Partners
SPH
+$3.95M
4
MS icon
Morgan Stanley
MS
+$3.93M
5
KLIC icon
Kulicke & Soffa
KLIC
+$3.41M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$4.61M
2
DPZ icon
Domino's
DPZ
+$3.96M
3
BRKR icon
Bruker
BRKR
+$3.65M
4
TJX icon
TJX Companies
TJX
+$3.62M
5
SBUX icon
Starbucks
SBUX
+$3.58M

Sector Composition

Rank Sector Weight
1 Healthcare 17.3%
2 Industrials 16.2%
3 Technology 12.7%
4 Financials 11.7%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CARG icon
876
CarGurus
CARG
$3.47B
$374K 0.04%
+11,892
New +$347K
APRN
877
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$374K 0.04%
+4,238
New +$223K
ALBO
878
DELISTED
Albireo Pharma Inc
ALBO
$374K 0.04%
+11,973
New +$370K
PRGS icon
879
Progress Software
PRGS
$1.76B
$373K 0.04%
+7,585
New +$349K
VLY icon
880
Valley National Bancorp
VLY
$8.04B
$373K 0.04%
+28,052
New +$362K
NUE icon
881
Nucor
NUE
$62.1B
$371K 0.04%
+3,762
New +$400K
SAGE
882
DELISTED
Sage Therapeutics
SAGE
$371K 0.04%
8,371
-9,010
-52% -$413K
BIOC
883
DELISTED
Biocept, Inc.
BIOC
$371K 0.04%
3,088
-1,963
-39% -$229K
LFCR icon
884
Lifecore Biomedical
LFCR
$190M
$370K 0.04%
+40,153
New +$437K
VOO icon
885
Vanguard S&P 500 ETF
VOO
$1.03T
$370K 0.04%
939
-622
-40% -$252K
XNCR icon
886
Xencor
XNCR
$1.55B
$369K 0.04%
+11,293
New +$371K
FE icon
887
FirstEnergy
FE
$27.5B
$368K 0.04%
+10,342
New +$393K
HQY icon
888
HealthEquity
HQY
$8.75B
$368K 0.04%
+5,688
New +$395K
UFCS icon
889
United Fire Group
UFCS
$1.4B
$368K 0.04%
15,943
+8,694
+120% +$217K
VOD icon
890
Vodafone
VOD
$37.4B
$368K 0.04%
23,816
+8,096
+52% +$134K
ADTN icon
891
Adtran
ADTN
$616M
$367K 0.04%
+19,586
New +$412K
MRTN icon
892
Marten Transport
MRTN
$1.22B
$367K 0.04%
23,367
-7,431
-24% -$117K
EPZM
893
DELISTED
Epizyme, Inc
EPZM
$367K 0.04%
+71,652
New +$435K
NCNO icon
894
nCino
NCNO
$2.1B
$365K 0.04%
5,141
-132
-3% -$8.8K
MRSH
895
Marsh
MRSH
$91.5B
$363K 0.04%
+2,397
New +$363K
RM icon
896
Regional Management Corp
RM
$303M
$363K 0.04%
+6,232
New +$344K
ECVT icon
897
Ecovyst
ECVT
$1.14B
$361K 0.04%
+30,963
New +$423K
DRH icon
898
Diamondrock Hospitality Co
DRH
$2.56B
$360K 0.04%
38,059
+25,889
+213% +$231K
PRGO icon
899
Perrigo
PRGO
$1.78B
$360K 0.04%
+7,601
New +$338K
OCFC icon
900
OceanFirst Financial
OCFC
$1.91B
$359K 0.04%
16,754
-19,580
-54% -$401K
34 35
36
37 38

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, GSA Capital Partners held 1,940 positions worth $982M, up 10% from $889M the previous quarter. Its ten largest holdings account for 4.7% of the portfolio.

GSA Capital Partners deployed $134M of net new capital in Q3 2021, opening 653 new positions and adding to 414 existing holdings. Its largest new stake was Openlane: 280,405 shares worth $4.6M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Amazon, an estimated $4.61M trimmed.

  • GSA Capital Partners's largest Q3 2021 buy was Openlane: 280,405 shares worth $4.6M.
  • GSA Capital Partners added most to BridgeBio Pharma in Q3 2021, an estimated $4.54M increase.
  • GSA Capital Partners's biggest Q3 2021 reduction was Amazon, cutting an estimated $4.61M.
  • GSA Capital Partners fully exited TJX Companies in Q3 2021, selling an estimated $3.62M.
  • GSA Capital Partners's ten largest holdings make up 4.7% of its $982M portfolio in Q3 2021.
  • GSA Capital Partners opened 653 new positions and closed 576 in Q3 2021.
  • GSA Capital Partners's portfolio value rose 10% quarter-over-quarter to $982M.

Based on GSA Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.